Remove services investment-banking-research
article thumbnail

Fuld partners with Finalis to support boutique Investment Banks

Fuld

BOSTON – MARCH 04, 2024 – Fuld & Company, an expanding research, analytics, and advisory consultancy, is pleased to announce a strategic partnership with Finalis, the world’s fastest-growing dealmaking platform. The post Fuld partners with Finalis to support boutique Investment Banks appeared first on Fuld & Co.

article thumbnail

Biologics Contract Manufacturing – Current Interest of the Pharmaceutical Industry

Roots Analysis

The above-mentioned factors have compelled many small developers, as well as certain pharma giants engaged in this domain, to outsource their manufacturing operations to contract service providers. It is worth noting that most of the contract service providers engaged in this domain have profound experience in niche and emerging areas.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Economics and risks of FDA’s Quality management maturity rating programme

European Pharmaceutical Review

The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceutical manufacturing site quality rating system, the Quality management maturity (QMM) programme.

article thumbnail

Life sciences must become cloud-first to seize the science of tomorrow

pharmaphorum

And that dynamism, innovation and collaboration are all qualities that the industry must continue to nurture as it faces the challenge of developing new medicines, treatments and services for the future. That presents a huge opportunity for research to develop more precise and personalised medicines. From face-to-face to FaceTime.

Vaccines 110
article thumbnail

Preventing the next pandemic: Infrastructure and global equity

pharmaphorum

The same operation also made significant investments in companies providing ancillary COVID-19 vaccine supplies , such as the production of needles and syringes. Companies such as Merck and Novartis provided manufacturing capacity to Pfizer and BioNTech for their vaccine, and Sanofi provided a similar service to Moderna.

Vaccines 114
article thumbnail

The Metaverse: Macroeconomic trends

Pharmaceutical Technology

This shift will be driven by the future of work and digital transformation initiatives ongoing across sectors ranging from retail to healthcare and financial services. The metaverse is still largely conceptual, but the growing volumes of investment in it derive from the belief that it is the future of the internet. Metaverse hype.

52
article thumbnail

The Metaverse: Macroeconomic trends

Pharmaceutical Technology

This shift will be driven by the future of work and digital transformation initiatives ongoing across sectors ranging from retail to healthcare and financial services. The metaverse is still largely conceptual, but the growing volumes of investment in it derive from the belief that it is the future of the internet. Metaverse hype.

52